Diabetic Medicine

Papers
(The H4-Index of Diabetic Medicine is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
136
Letter to the editor: Nuances from the manufacturer regarding the ABCD‐DTN best practice guide on the use of MiniMed 780G advanced hybrid closed loop system70
Utility of screening for silent myocardial ischaemia in diabetes with an annual electrocardiogram57
Issue Information55
Lack of consideration of socioeconomic factors in transition programme of adolescents with type 1 diabetes: A systematic review51
Satisfaction with diabetes involvement: Exploring parent and adolescent perspectives45
Update on technologies, medicines and treatments41
Design, recruitment and baseline characteristics of the LENS trial41
Mesenchymal stromal cell secretory molecules improve the functional survival of human islets39
A cognitive behavioural model of the bidirectional relationship between disordered eating and diabetes self care in adult men with Type 1 diabetes mellitus37
Investigating health professionals' perspectives and experiences of food security‐related conversations in diabetes care36
Effect of switching from intermittently scanned to real‐time continuous glucose monitoring on glycaemic outcomes in adults with type 1 diabetes: A real‐world, Canadian retrospective study36
Profiles of disordered eating behaviour in type 1 diabetes using the DEPS‐R and behaviour and glycaemic outcomes in a real‐life setting33
Systematic review of technology‐mediated peer support interventions in paediatric type 1 diabetes care31
Exploring inequities in access to diabetes technologies among children and young people with type 1 diabetes: Perspectives of parents and young people from ethnic minority groups and low socio‐economi31
Autopsy of a telephone‐based peer support intervention: Exploring participants' perspectives of and experiences with a self‐management support model for adults with type 2 diabetes from speciality car30
A validation study of the Intentional Nonadherence Scale among people with type 2 diabetes in the United Kingdom30
Exploring low‐dose glucagon for exercise‐induced hypoglycaemia in type 1 diabetes: A randomised controlled trial29
Hybrid closed‐loop insulin delivery improves glycaemic control compared with sensor‐augmented pump therapy: A meta‐analysis of ‘free‐living’ randomised trials in type 1 diabetes29
Improving equity in diabetes technology use: Voices of youth and their parents26
Lantidra (donislecel) in type 1 diabetes: An in‐depth analysis of pharmacology, clinical effectiveness, safety, and the therapeutic role of the first FDA 25
Associations between weight self‐stigma and healthy diet and physical activity among adults with type 2 diabetes: Cross‐sectional results from the second Diabetes MILES – Australia (MILES‐2) study25
Reply to Besançon et al. regarding ‘Marked improvement in HbA1c following introduction of biosimilar insulin to treatment regimen of children and you25
Gestational diabetes: One size does not fit all—an observational study of maternal and neonatal outcomes by maternal glucose profile25
Outcomes measured in studies assessing health systems interventions for type 1 diabetes management: A scoping review25
0.49345993995667